Management of Babesia divergens babesiosis without a complete course of quinine treatment

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 9, 1999, Pages 672-673

  Denes, E ^a   Rogez, J P ^a   Darde M L ^a   Weinbreck, P ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; CLINDAMYCIN; QUININE;

ADULT; ARTICLE; BABESIA DIVERGENS; BABESIOSIS; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032728417     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050373     Document Type: Article

References (5)

1. 1. Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TPM: Human babesiosis. Annals of Tropical Medicine and Parasitology (1998) 92:489-501
2. 2. Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ: Quinine in the treatment of Babesia divergens infection in humans. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:840-841
3. 3. Skrabalo Z, Deanovic Z: Piroplasmosis in man: report on a case. Documenta Medica Geographica Tropica (1957) 9:11-16
4. 4. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL: Human babesiosis in New York state: an epidemiological description of 136 cases. Clinical Infectious Diseases (1992) 15:1019-1023
5. 5. Boustani MR, Gelfand JA: Babesiosis. Clinical Infectious Diseases (1996) 22:611-615